At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 7 enrolled
Drug / intervention
Metronidazole gel 1 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Bioavailability of Metronidazole Dermal Products
In Brief
A Early Phase 1 clinical trial evaluating Metronidazole gel 1, Metronidazole gel 2, and 1 other intervention for Bioequivalence. Completed, enrolled 7 participants across 1 site.
Detailed Summary
Generate human PK data by collecting data following the application of metronidazole formulations.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBioequivalence
CountriesUnited States
CollaboratorsFood and Drug Administration (FDA)
Timeline
Early Ph 1CompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartApr 2019
Primary CompletionOct 2019
Study CompletionNov 2019
TodayJul 2026
First PostedSep 5, 2017
Enrollment StartApr 9, 2019
Primary CompletionOct 31, 2019
Study CompletionNov 3, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.8 years ago
Interventions
Metronidazole gel 1drug
RLD gel
Metronidazole gel 2drug
generic gel
Metronidazole creamdrug
generic cream